Skip to main content
SpringerLink
Log in

23 De voorspellende waarde van pretherapie tumorvolume bij patiënten met intermediate risk MSKCC-gemetastaseerd niercelcarcinoom

  • Abstracts
  • Published:
Tijdschrift voor Urologie Aims and scope Submit manuscript

Samenvatting

Patiënten met gemetastaseerd niercelcarcinoom reageren verschillend op targeted therapie, zelfs als de MSKCC- en Heng-scores vergelijkbaar zijn. Deze studie is opgezet om te analyseren of het tumorvolume een voorspellende waarde is van de overleving.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Sint Lucas Andreas Ziekenhuis, Amsterdam, The Netherlands

    R.E. de Bruijn, J. Nijkamp, A. Noe, S. Horenblas, J.B.A.G. Haanen, W. Prevoo & A. Bex

Authors
  1. R.E. de Bruijn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Nijkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Noe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Horenblas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J.B.A.G. Haanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Prevoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Bex
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Bruijn, R., Nijkamp, J., Noe, A. et al. 23 De voorspellende waarde van pretherapie tumorvolume bij patiënten met intermediate risk MSKCC-gemetastaseerd niercelcarcinoom. Tijdschrift voor Urologie 4, 168–169 (2014). https://doi.org/10.1007/s13629-014-0096-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13629-014-0096-2

Search

Navigation